These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9436085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A.
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [Abstract] [Full Text] [Related]

  • 4. Silence is not always golden in medical decision-making.
    Paris JJ, Moreland MP.
    Am J Bioeth; 2007 Jul; 7(7):39-40. PubMed ID: 17654383
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Responses to open peer commentaries on "Physicians' silent decisions: because patient autonomy doesn't always come first".
    Whitney SN, McCullough LB.
    Am J Bioeth; 2007 Jul; 7(7):W1-3. PubMed ID: 17654368
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Jan 21; 49(2):28-31. PubMed ID: 10680601
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Women in early phase trials: an IRB's deliberations.
    Anderson JR, Schonfeld TL, Kelso TK, Prentice ED.
    IRB; 2003 Jan 21; 25(4):7-11. PubMed ID: 14649248
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ethical considerations.
    Treiman DM.
    Epilepsy Res Suppl; 1993 Jan 21; 10():137-48. PubMed ID: 8251089
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Accutane risk management program strengthened.
    FDA Consum; 2002 Jan 21; 36(1):8. PubMed ID: 11881607
    [No Abstract] [Full Text] [Related]

  • 17. [Can be treated with isotretinoin patients with acne and Gilbert's syndrome?].
    Suárez Crespo JF, García Mellado V, Becerra Massare P, Martín-Vivaldi Martínez R.
    Rev Esp Enferm Dig; 1996 Aug 21; 88(8):584-5. PubMed ID: 8962771
    [No Abstract] [Full Text] [Related]

  • 18. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA, Paulozzi LJ, Erickson JD.
    Teratology; 2001 Sep 21; 64(3):142-7. PubMed ID: 11514944
    [Abstract] [Full Text] [Related]

  • 19. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
    Doshi A.
    Seton Hall Law Rev; 2007 Sep 21; 37(2):625-60. PubMed ID: 17294569
    [No Abstract] [Full Text] [Related]

  • 20. Management of adult acne and acne variants.
    Cunliffe WJ.
    J Cutan Med Surg; 1998 May 21; 2 Suppl 3():7-13. PubMed ID: 9873117
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.